Osimertinib vs Pravastatin
Osimertinib vs Pravastatin: Overview
This comparison examines the pharmacological differences between Osimertinib and Pravastatin.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pravastatin: Competitive inhibitor of HMG-CoA reductase.
Pharmacokinetics
Half-life: Osimertinib β 48 hours; Pravastatin β 1.8 hours.
Chemical Properties
Molecular Formula: Osimertinib β C28H33N7O2; Pravastatin β C23H36O7.
Molecular Weight: Osimertinib β 499.6050 g/mol; Pravastatin β 424.5280 g/mol.
Type: Osimertinib β Small molecule; Pravastatin β Small molecule.